³Ô¹ÏÍøÕ¾

Latest

Latest lung cancer News | Page 3

  • Latest lung cancer news stories and updates. What is happening today? All recent lung cancer news and developments. Live coverage and timeline of lung cancer. All you need to know about lung cancer.
Even small amounts of physical activity could be valuable in late-stage lung cancer
New respite care facility coming soon to Queanbeyan
Breathing highway air increases blood pressure, UW research finds 
Asbestos still risk to workers 20 years on from ban
New WHO campaign highlights tobacco industry tactics to influence public health policies
Smoking is the leading cause of chronic obstructive pulmonary disease
Are you silica smart?
How cancer works – decade’s research unlocks secrets
One punch isn’t enough to overcome a common cancer mutation
New centre to develop treatments for aggressive cancers
About 100 people a month are diagnosed with lung cancer in WA
Australia’s tenth annual ³Ô¹ÏÍøÕ¾ Asbestos Awareness Month launches new Asbestos Education resource for residential property owners, managers and tradies to help save lives
Dom’s Finding strength in being open about cancer
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer
Construction blitz to target falls from height and asbestos  
Tagrisso plus chemotherapy reduced the risk of disease progression in the brain by 42% in patients with EGFR-mutated advanced lung cancer and…
Important workers compensation reforms supporting fire-fighters pass Parliament
COVID-19 first infectious disease in top 5 causes of death since 1970
New target to beat cancer drug resistance
Progressing nation-leading reforms for our firefighters
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
Enhertu demonstrated strong and durable tumour responses in previously treated HER2-mutant advanced lung cancer in DESTINY-Lung02 Phase II trial
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
Leading the way in health and safety for Tasmania’s fire-fighters
Action still required to eliminate the harm caused by engineered stone
AstraZeneca data at WCLC advance ambition to have an AstraZeneca medicine for more than half of all patients treated for lung cancer by 2030
Immutep receives positive scientific advice from the European Medicines Agency
A novel strategy to suppress triple negative breast cancer growth
Greens introduce bill to expand presumptive cancer scheme for Victorian firefighters
Surviving lung cancer is just beginning
Australians living longer but dementia and Alzheimer’s a greater risk
$1.1 million for breakthrough lung disease scanner
Breakthrough lung disease scanner
Keep your lungs strong and healthy this winter with Lung Foundation Australia
Datopotamab deruxtecan met dual primary endpoint of progression-free survival in patients with advanced non-small cell lung cancer in TROPION-Lung01 Phase III trial
First method to assess exposure to common sleep disorder
First method to access exposure to common sleep disorder
Donation allows scientists to explore asbestos treatments
Engineered stone may break my bones, but its dust will hurt workers’ lung
Firefighter cancer scheme would be expanded under Greens’ bill
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
Tagrisso achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Remagine Art Prize 2023 winner announced
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
New treatment promises to increase lung cancer survival

© 2025 - ³Ô¹ÏÍøÕ¾